康诺亚-B(02162)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02162 康诺亚-B

未开盘 11-06 16:08:52

69.300

-0.850

-1.21%

最高71.350	最低67.350	成交量124.90万
今开67.600	昨收70.150	日振幅5.70%
总市值207.21亿	流通市值207.21亿	总股本2.99亿
成交额8,683万	换手率0.42%	流通股本2.99亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02162","market":"HK","secType":"STK","nameCN":"康诺亚-B","latestPrice":69.3,"timestamp":1793952532003,"preClose":70.15,"halted":0,"volume":1249000,"delay":0,"changeRate":-0.012116892373485509,"floatShares":299000000,"shares":299000000,"eps":-1.91,"marketStatus":"未开盘","change":-0.85,"latestTime":"11-06 16:08:52","open":67.6,"high":71.35,"low":67.35,"amount":86833825,"amplitude":0.057021,"askPrice":69.3,"askSize":1000,"bidPrice":69.25,"bidSize":500,"shortable":3,"etf":0,"ttmEps":3.044545,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":0,"adr":0,"listingDate":1625673600000,"exchange":"SEHK","adjPreClose":70.15,"openAndCloseTimeList":[[1793928600000,1793937600000],[1793941200000,1793952000000]],"volumeRatio":0.3358856700166195,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02162","defaultTab":"news","newsList":[{"id":"2680740658","title":"汇添富基金管理股份有限公司减持康诺亚-B(02162.HK)99.1万股 每股作价约70.9港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680740658","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680740658?lang=zh_cn&edition=full","pubTime":"2026-11-03 19:13","pubTimestamp":1793704425,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","BK1574","BK1161","02162","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115252433","title":"康诺亚-B：东方证券股份有限公司（DFZQ）减持，好仓比例降至4.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115252433","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115252433?lang=zh_cn&edition=full","pubTime":"2026-11-03 17:15","pubTimestamp":1793697303,"startTime":"0","endTime":"0","summary":"东方证券股份有限公司（DFZQ）于2026年10月27日在联交所场内以每股均价70.8951港元卖出康诺亚-B（02162）股份99.10万股，涉资约7025.70万港元，属场内主动交易，即在二级市场直接买卖股份。东方证券股份有限公司（DFZQ）此次减持前持有康诺亚-B好仓1518.85万，占比5.08%；减持后持股量为1419.75万，好仓比例降至4.75%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680124377","title":"港股异动 | 创新药概念股延续跌势 金斯瑞生物科技(01548)跌超15% 康诺亚-B(02162)跌近5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680124377","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680124377?lang=zh_cn&edition=full","pubTime":"2026-11-03 14:45","pubTimestamp":1793688352,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，创新药概念股延续跌势，截至发稿，金斯瑞生物科技跌15.66%，报30.16港元；歌礼制药-B跌7.68%，报4.39港元；荣昌生物跌5.46%，报62.3港元；康诺亚-B跌4.88%，报63.3港元。消息面上，在此次ESMO大会上，有部分药物数据不及预期。另有一款HER2 ADC全球III期达到主要终点PFS，但潜在获益有限。市场人士表示，不可忽视创新药研发风险。政策实质是收紧股权类合作，而非阻断产品出海。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1517676.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","01672","LNGR","MEDX","09995","HK0000306685.HKD","HK0000320223.HKD","BK1583","HK0000306701.USD","BK1587","02162","BK1515","BK1576","BK4588","HK0000320264.USD","KCAI","BK4585","LU1969619763.USD","06978","IBBQ","BK1161","LU2328871848.SGD","BK1141","159992","VXUS","01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129249426","title":"异动解读｜康诺亚-B盘中下跌5.03%，股东减持后股本仍无变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1129249426","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129249426?lang=zh_cn&edition=full","pubTime":"2026-11-03 13:34","pubTimestamp":1793684097,"startTime":"0","endTime":"0","summary":"11月3日，康诺亚-B盘中下跌5.03%，报63.2港元，成交额2.27亿港元。近期可对应的公开消息主要有两项：其一，公司披露10月股份变动月报，10月期间无新增发行、回购、注销或库存股变动，整体股本结构维持稳定；其二，汇添富基金管理股份有限公司于10月27日在场内减持99.1万股，均价70.8951港元，套现约7025.7万港元，减持后好仓比例由5.08%降至4.75%。从时点看，最新披露的月报本身偏中性，但此前股东持股比例跌破5%具有更直接的交易层面信号，或为股价承压背景之一。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"康诺亚-B遭股东减持，盘中承压下行","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190734901","title":"康诺亚-B10月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1190734901","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190734901?lang=zh_cn&edition=full","pubTime":"2026-11-02 17:36","pubTimestamp":1793612197,"startTime":"0","endTime":"0","summary":"康诺亚生物医药科技有限公司于2026年11月2日发布10月股份变动月报表，披露2026年10月期间公司无新增发行或回购、注销及库藏股变动，整体股本结构保持稳定。根据公告，截至2026年10月31日，康诺亚生物医药科技有限公司法定注册股本仍为500,000,000股，每股面值USD0.0001，合计USD50,000。本次公告由公司执行董事Bo CHEN博士签署，康诺亚生物医药科技有限公司确认遵守香港联合交易所有限公司《上市规则》和相关法律法规的要求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680717785","title":"【券商聚焦】中信证券：国内医药板块业绩持续修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2680717785","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680717785?lang=zh_cn&edition=full","pubTime":"2026-11-02 08:40","pubTimestamp":1793580014,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券发布2027年医疗健康行业投资策略，“十五五”开局之年，医药行业首次列为国家新兴支柱产业，紧随其后的价格机制优化改革 、支持创新药械高定价、以及推动商业医疗保险发展等行业增量改革政策趋势，叠加国内医药行业在创新领域集中兑现等产业内外催化因素驱动下，该机构看到2026H1国内医药板块业绩持续修复，尤其是创新药、创新器械等新兴产业板块。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1994936","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","KCE","01276","HK0000320264.USD","BK0028","01093","LU0455707207.USD","LU0588546209.SGD","01952","LU1969619763.USD","LU0348825331.USD","01951","09939","02162","02268","LU0823426480.USD","LU0708995153.HKD","02273","06078","00013","LU0607220059.USD","KURE","LU0708995583.HKD","01530","02269","06821","01548","LU0348766576.USD","09996","LU0039217434.USD","01177","159938","09966","IE00B031HY20.USD","06030","06996","600030","LU0828237510.HKD","LU1064131003.USD","03759","03692","02596","09926","LU1226287529.USD","06990","01801","06160","LU1794554557.SGD","02096","LU0979878070.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679167662","title":"汇添富基金减持康诺亚(02162)99.1万股 每股作价约70.9港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679167662","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679167662?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:36","pubTimestamp":1793360176,"startTime":"0","endTime":"0","summary":"10月27日，汇添富基金管理股份有限公司减持康诺亚(02162)99.1万股，每股作价70.8951港元，总金额约为7025.70万港元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20261030/20261030193652_27966.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20261030/20261030193652_27966.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1516428.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","EWH","02162","BK1574","BK1587","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165711354","title":"康诺亚-B：汇添富基金管理股份有限公司减持，好仓比例降至4.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165711354","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165711354?lang=zh_cn&edition=full","pubTime":"2026-10-30 17:14","pubTimestamp":1793351680,"startTime":"0","endTime":"0","summary":"汇添富基金管理股份有限公司于2026年10月27日在联交所场内以每股均价70.8951港元卖出康诺亚-B（02162）股份99.10万股，涉资约7025.70万港元。该笔为场内主动交易，透过联交所公开市场撮合成交，属二级市场直接买卖。汇添富基金管理股份有限公司此次减持前持有康诺亚-B好仓1518.85万，占比5.08%；减持后持股量为1419.75万，好仓比例降至4.75%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121143032","title":"康诺亚-B（02162）授权受托人动用约1亿港元购股 用于2022年受限制股份单位计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1121143032","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121143032?lang=zh_cn&edition=full","pubTime":"2026-10-29 21:20","pubTimestamp":1793280034,"startTime":"0","endTime":"0","summary":"2026年10月29日，康诺亚生物医药科技有限公司发布自愿性公告称，公司董事会已授权独立专业受托人根据2022年1月21日采纳的受限制股份单位计划，在公开市场以现行市价动用约1亿港元购买公司普通股。公告显示，上述股份购入将由受托人以信托方式持有，并用于未来根据2022年受限制股份单位计划向合资格人士授予股份奖励。公司提醒股东及潜在投资者在买卖公司证券时保持审慎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679288936","title":"康诺亚-B(02162.HK)拟根据2022年受限制股份单位计划购买股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2679288936","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679288936?lang=zh_cn&edition=full","pubTime":"2026-10-29 21:14","pubTimestamp":1793279668,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1574","BK1583","BK1587","02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678976455","title":"港股异动 | 康诺亚-B(02162.HK)再跌超3% 里昂指CLARITY-Gastric 01重大临床数据公布后市场情绪疲弱","url":"https://stock-news.laohu8.com/highlight/detail?id=2678976455","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678976455?lang=zh_cn&edition=full","pubTime":"2026-10-28 15:35","pubTimestamp":1793172941,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1587","BK1583","02162","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678159432","title":"【券商聚焦】国金证券维持康诺亚-B（02162）买入评级 指核心产品临床获益显著","url":"https://stock-news.laohu8.com/highlight/detail?id=2678159432","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678159432?lang=zh_cn&edition=full","pubTime":"2026-10-28 13:38","pubTimestamp":1793165901,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国金证券发布研报指，康诺亚-B 核心产品CMG901全球III期CLARITY-Gastric01研究结果在ESMO 2026公布。该研究入组2L+晚期CLDN18.2阳性胃食管癌患者，3L+约占66%。G7 2L+ HER2阴性胃癌患者超5万人，中国超20万人，约60%为CLDN18.2≥25%；CMG901以≥25%为阳性阈值，可及人群较现有疗法扩大一倍。后续1L胃癌III期CLARITY-Gastric02已于2026M3完成首例给药，胆道癌/胰腺癌II期推进中。国金证券预测康诺亚-B 2026-2028年收入分别为28.71/25.54/29.94亿元（人民币），同比+300.8%/-11.03%/+17.22%；净利润10.75/4.05/6.00亿元，对应EPS 3.60/1.35/2.01元。研报维持“买入”评级。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1994638","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCE","02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170919541","title":"异动解读｜康诺亚-B盘中下跌14.14%，近期公布CLDN18.2 ADC CMG901全球III期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1170919541","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170919541?lang=zh_cn&edition=full","pubTime":"2026-10-27 15:44","pubTimestamp":1793087099,"startTime":"0","endTime":"0","summary":"10月27日，康诺亚-B盘中下跌14.14%，报69.55港元，成交额7.32亿港元。消息面上，公司当日被报道一度跌超16%，催化剂为近期公布CLDN18.2 ADC产品CMG901全球III期数据。此前公司股价曾受康悦达收入高增、青少年特应性皮炎新适应症获批及券商上调目标价等利好推动走强；其中前三季度康悦达收入约6.6亿元，同比增长约227%。在前期涨幅与利好多重兑现后，最新临床数据披露引发股价大幅波动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"康诺亚公布III期数据，股价盘中下跌","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678702147","title":"港股异动 | 康诺亚-B(02162.HK)一度跌超16%  近期公布CLDN18.2 ADC CMG901全球III期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2678702147","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678702147?lang=zh_cn&edition=full","pubTime":"2026-10-27 14:06","pubTimestamp":1793081208,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1587","BK1161","BK1583","02162","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154287539","title":"港股创新药概念股早盘走高！丽珠医药飙逾10%领涨，多家中国药企亮相ESMO年会，核心临床数据有望成股价催化剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1154287539","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154287539?lang=zh_cn&edition=full","pubTime":"2026-10-26 10:16","pubTimestamp":1792981015,"startTime":"0","endTime":"0","summary":"据国联民生证券研究显示，本届ESMO年会合计有96项最新突破成果摘要公布，其中31项为中国公司旗下药物相关研究。预计多项核心数据有望成为相关上市公司的近期股价催化剂。华泰证券发布研报表示，近日ADC赛道进展频现。ESMO年会上，多款ADC类药物展现良好疗效，继续验证其作为下一代肿瘤治疗基石药物的潜力。和ADC有关的授权交易持续落地，交易金额持续走高。","market":"hk","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162","09995","02359","06990","09688","01548","01801","01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677992942","title":"汇添富基金管理股份有限公司增持康诺亚-B(02162.HK)24.2万股 每股作价约87.96港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677992942","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677992942?lang=zh_cn&edition=full","pubTime":"2026-10-23 19:25","pubTimestamp":1792754745,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02162","BK1583","BK1574","BK1161","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677943834","title":"港股异动 | 康诺亚-B(02162.HK)涨超5% 康悦达医保内持续放量 自研CDH17 ADC CM518D1临床数据入选ESMO","url":"https://stock-news.laohu8.com/highlight/detail?id=2677943834","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677943834?lang=zh_cn&edition=full","pubTime":"2026-10-23 14:21","pubTimestamp":1792736476,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1583","02162","BK1587","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677919874","title":"中金：上调康诺亚-B(02162.HK)目标价12.24%至110港元 维持“跑赢行业”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2677919874","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677919874?lang=zh_cn&edition=full","pubTime":"2026-10-23 10:05","pubTimestamp":1792721150,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1587","02162","BK1574","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106938587","title":"异动解读｜康诺亚-B盘中下跌5.63%，券商下调评级至中性并给出27元目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1106938587","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106938587?lang=zh_cn&edition=full","pubTime":"2026-10-22 11:51","pubTimestamp":1792641060,"startTime":"0","endTime":"0","summary":"10月22日，康诺亚-B盘中下跌5.63%，报81.3港元，成交额1.1亿港元。消息面上，市场最新出现券商将公司评级下调至中性、目标价27元人民币的公开信息，对股价形成压制。此前公司核心产品康悦达前三季度收入约6.6亿元，同比增长约227%，且青少年中重度特应性皮炎新适应症获批上市，基本面曾获积极催化；但本次盘中走弱对应的最新公开信息为评级调整。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"康诺亚遭券商降级至中性，盘中走弱","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676665654","title":"港股异动 | 康诺亚-B(02162.HK)午后涨超6% 康悦达青少年特应性皮炎适应症获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2676665654","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676665654?lang=zh_cn&edition=full","pubTime":"2026-10-20 13:54","pubTimestamp":1792475682,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02162","BK1583","BK1574","BK1161","BK1587"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0336},{"period":"1month","weight":-0.1058},{"period":"3month","weight":-0.1533},{"period":"6month","weight":-0.0368},{"period":"1year","weight":0.1657},{"period":"ytd","weight":0.2965}],"compareEarnings":[{"period":"1week","weight":0.051},{"period":"1month","weight":0.0146},{"period":"3month","weight":-0.0462},{"period":"6month","weight":-0.0724},{"period":"1year","weight":-0.0757},{"period":"ytd","weight":-0.0448}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康诺亚生物医药科技有限公司是一家生物科技公司，专注于自主发现及开发自体免疫及肿瘤治疗领域的创新生物疗法的公司。该公司还专注于医药产品的研究和开发。该公司的主要产品有CM310、CM326、CM313和CM383，可治疗各种成人、青少年及儿童I型免疫性疾病，例如中重度特应性皮炎、中重度哮喘、慢性鼻賨炎伴鼻息肉、过敏性鼻炎，亦可能可以治疗慢性阻塞性肺疾病。该公司还建立了涵盖生物药开发的关键功能的全面一体化平台。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.062159},{"month":2,"riseRate":0.6,"avgChangeRate":0.057033},{"month":3,"riseRate":0.4,"avgChangeRate":0.01927},{"month":4,"riseRate":1,"avgChangeRate":0.079263},{"month":5,"riseRate":0.2,"avgChangeRate":-0.114444},{"month":6,"riseRate":1,"avgChangeRate":0.128513},{"month":7,"riseRate":0.6,"avgChangeRate":0.112367},{"month":8,"riseRate":0.666667,"avgChangeRate":0.036143},{"month":9,"riseRate":0.833333,"avgChangeRate":0.050215},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.02702},{"month":11,"riseRate":0.666667,"avgChangeRate":0.043668},{"month":12,"riseRate":0.2,"avgChangeRate":-0.144855}],"exchange":"SEHK","name":"康诺亚-B","nameEN":"KEYMED BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康诺亚-B(02162)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康诺亚-B(02162)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康诺亚-B,02162,康诺亚-B股票,康诺亚-B股票老虎,康诺亚-B股票老虎国际,康诺亚-B行情,康诺亚-B股票行情,康诺亚-B股价,康诺亚-B股市,康诺亚-B股票价格,康诺亚-B股票交易,康诺亚-B股票购买,康诺亚-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康诺亚-B(02162)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康诺亚-B(02162)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}